BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve 1. Un-Audited financial Results for the quarter ended 30.06.2024. 2.To review the requests of the promoters for reclassification. 3. To convene 37th Annual General Meeting of the Company. 4. To Decide on Book Closure dates. 5. Other AGM related matters. 6. Allotment of equity shares to the employees of the Company upon conversion of stock options.